Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Asia Congress 2019

Presidential session

Brigatinib vs crizotinib in patients with ALK inhibitor-naive advanced ALK+ NSCLC: Updated results from the phase III ALTA-1L trial

Date

23 Nov 2019

Session

Presidential session

Topics

Tumour Site

Thoracic Malignancies

Presenters

Ross Camidge

Citation

Annals of Oncology (2019) 30 (suppl_9): ix183-ix202. 10.1093/annonc/mdz446

Authors

R. Camidge1, H.R. Kim2, M. Ahn3, J.C. Yang4, J. Han5, M.J. Hochmair6, K.H. Lee7, A. Delmonte8, M.R. Garcia Campelo9, D. Kim10, F. Griesinger11, E. Felip12, R. Califano13, A. Spira14, S. Gettinger15, M. Tiseo16, Q. Ni17, P. Zhang18, S. Popat19

Author affiliations

  • 1 Medical Oncology, University of Colorado Cancer Center, 80045 - Aurora/US
  • 2 Yonsei Cancer Center, Division Of Medical Oncology, Yonsei University Severance Hospital, Seoul/KR
  • 3 Hematology-oncology, Samsung Medical Center, 135-710 - Seoul/KR
  • 4 Department Of Oncology, National Taiwan University Hospital, Taipei/TW
  • 5 N/a, National Cancer Center, Goyang/KR
  • 6 Department Of Respiratory And Critical Care Medicine, Department of Respiratory and Critical Care Medicine, Krankenhaus Nord – Klinik Floridsdorf, Vienna/AT
  • 7 Chungbuk National University College Of Medicine, Chungbuk National University Hospital, Cheongju/KR
  • 8 N/a, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola/IT
  • 9 N/a, Complejo Hospitalario Universitario A Coruna Hospital Teresa Herrera-Materno Infantil, Coruna/ES
  • 10 Department Of Internal Medicine, Seoul National University Hospital, 110-744 - Seoul/KR
  • 11 Pius-hospital Oldenburg, Pius-Hospital Oldenburg, University of Oldenburg, Oldenburg/DE
  • 12 Medical Oncology Service (lung Cancer Unit)  , Vall d'Hebron University Hospital, 08035 - Barcelona/ES
  • 13 Department Of Medical Oncology, The Christie NHS Foundation Trust, Manchester/GB
  • 14 N/a, Virginia Cancer Specialists and US Oncology Research, The Woodlands/US
  • 15 N/a, Yale Cancer Center, New Haven/US
  • 16 Medical Oncology Unit, University Hospital of Parma, Parma/IT
  • 17 N/a, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge/US
  • 18 Oncology Clinical Research, Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge/US
  • 19 Medicine, Royal Marsden Hospital, SW3 6JJ - London/GB

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Invited Discussant LBA1

Presenter: Sai-Hong Ou

Session: Presidential session

Resources:

Slides

Webcast

Invited Discussant LBA2

Presenter: David Planchard

Session: Presidential session

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.